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This special issue of Neurochemical Research includes 
manuscripts from several investigators throughout the 
world who have been close colleagues and friends of Vit-
torio Gallo, and want to honor him for his contributions 
to our understanding of glutamatergic and GABAergic 
transmission during brain development, and to his leader-
ship in the field of neural development and regeneration.
While growing up in Rome, Italy, Vittorio displayed a 
very early passion for art. While his parents would have 
wagered that he would pursue a major in art history, Vitto-
rio was inspired by how the brain processes visual stimuli to 
perceive art, leading him to study chemistry, with a specific 
interest in neurobiology and neurochemistry. His coursework 
in biochemistry, biophysics and molecular biology at the 
University of Rome provided him with a solid foundation to 
understand the functioning of the brain, as well as rigorous 
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paradigms to be applied to his future research. All these 
aspects of his pre-doctoral studies converged when he was 
accepted to work with Prof. Giulio Levi at the Institute of 
Cell Biology (ICB) of the National Research Council (CNR) 
in Rome for his thesis—a decision that would completely 
change both his research career and his life.
ICB was an international and dynamic research institute 
directed by Nobel laureate Prof. Rita-Levi-Montalcini, who 
was Vittorio’s co-mentor during his PhD thesis. At ICB, 
Vittorio worked for 4 years with Prof. Giulio Levi as a stu-
dent and continued to collaborate with him for a number of 
years after his PhD. During these years, his research focused 
on amino acid neurotransmitters in the brain, in particular 
on mechanisms glutamate and GABA release from nerve 
terminals, and how neurons acquire different mechanisms 
of neurotransmitter release throughout development. His 
work was also influenced by a number of researchers who 
were investigating how metabolic compartmentalization in 
neurons and glia would affect utilization of different meta-
bolic precursors of glutamate and GABA. The work by Arne 
Schousboe, Leif Hertz, Abel Lajtha and others continuously 
inspired his work during these years.
The environment at IBC strongly influenced Vittorio’s 
career, as he decided that his work should focus on intact 
CNS neurons and the understanding of the mechanisms that 
would regulate their development, including acquisition of 
release mechanisms for specific neurotransmitters. There-
fore, after obtaining his Ph.D. in 1979, Vittorio obtained an 
EMBO Fellowship to join the MRC Developmental Neu-
robiology Unit in London directed by Prof. Robert Balazs. 
During these years he focused his studies on cerebellar 
development and glutamatergic transmission. Specifically, 
he helped develop the cerebellar granule cell cultures as a 
model system to study how electrical activity and voltage-
dependent calcium channels modulate granule neuron devel-
opment and glutamate release. He also co-authored several 
important publications on topics related to release and 
uptake of the neurotransmitter amino acids glutamate and 
GABA. The adjacent review by the Guest Editor shows these 
publications had an important impact on the scientific work 
of the Guest Editor of this special issue of Neurochemical 
Research. Finishing the Post-Doc period in London, Vittorio 
went on to join the Laboratory of Preclinical Pharmacol-
ogy at NIMH as an NIH Visiting Fellow (1983–1984) and, 
together with Dr. Flora Vaccarino, he developed a biochem-
ical/neuropharmacological assay to monitor the effects of 
GABA receptor modulators on the activity GABA chloride 
channels in live neurons. In spite of geographical constraints 
Vittorio and Flora became lifelong friends and more recently 
collaborated on a number of projects focusing on neonatal 
brain injury and regeneration.
Vittorio then returned to Rome to work as Senior 
Investigator at the Unit of Neurobiology, Laboratory of 
Physiopathology, Istituto Superiore di Sanita’ for an 8-year 
period. While still being associated with the Institute in 
Rome, he worked again in London as an EMBO Fellow in 
the laboratory of Prof. Stuart Cull-Candy, where he sought 
to resolve a controversial topic in glial physiology, i.e. deter-
mining whether astrocytes expressed functional glutamate-
activated membrane channels or only electrogenic glutamate 
transporters. He and Maria Usowicz, a doctoral candidate 
at that time, used patch-clamp recording and single channel 
analysis to demonstrate for the first time that indeed astro-
cytes expressed glutamate-activated channels that displayed 
functional properties similar to their neuronal counterparts.
In 1989, Vittorio moved to the US in the NIH intramural 
program, where he was Adjunct Scientist and NATO Fellow 
at the Laboratory of Developmental Neurobiology, NICHD. 
It was there that he characterized one of the spliced isoforms 
of the AMPA receptor subunit gene Gria4, and demonstrated 
that this isoform was highly expressed in cerebellum. He 
then became Chief of the Unit of Neurobiology, Laboratory 
of Cellular and Molecular Neurophysiology, NICHD, NIH 
(1992–1995), followed by continuing as a Tenured Inves-
tigator position from 1995 to 2001. During these years, he 
established his own research program with a focus on glial 
development and neuron–glial signaling in the CNS. He 
worked on oligodendrocyte progenitor cells (OPCs), their 
developmental and physiological properties, and the signal-
ing pathways that regulated their proliferation and differen-
tiation. During this time, he and his team demonstrated that 
both glutamate and GABA regulate OPC proliferation and 
differentiation. He also revealed that a number of membrane 
voltage-activated channels are tightly regulated in OPC dur-
ing cell cycle progression.
In 2002, Vittorio made another critical decision in his 
career. Drawing from his years of concentration on brain 
development, he sought an opportunity to build a program 
around the central issue of how dysregulated neural develop-
ment leads to neurodevelopmental disorders and neurologic 
disabilities. He moved from NICHD to Children’s National 
Hospital, where he was tasked with building the Center for 
Neuroscience Research and Children’s National Research 
Institute (CNRI). The environment of this new institution 
proved to be ideal for his goals to recruit young and dynamic 
investigators—both PhDs researchers and MD clinicians—
to create a truly interdisciplinary neuroscience program 
that would integrate lab-based and clinical research. From 
2002 to 2017 he has been Wolf-Pack Chair in Neuroscience, 
Director of Center for Neuroscience Research, and Director 
of the District of Columbia Intellectual and Developmental 
Disabilities Research Center (DC-IDDRC), one of the 14 
IDDCs in the US supported by NICHD. During this time at 
CNRI, he not only continued his research on glial develop-
ment and neuron–glia interactions, but also started a new 
collaboration with Prof. Flora Vaccarino at the Child Study 
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Center, Yale University School of Medicine. This collabo-
ration was focused on neonatal brain injury, with an aim to 
understand the cellular and molecular basis of white matter 
abnormalities caused by hypoxic/ischemic injury of the brain 
and its functional and behavioral long-term consequences. 
During this time, he and Joseph Scafidi (a pediatric neurolo-
gist at Children’s National who was being mentored by Vit-
torio) demonstrated that a non-invasive intervention based 
on intranasal EGF application after neonatal brain injury 
promoted oligodendrocyte and myelin regeneration, and 
subsequent functional and behavioral recovery. Vittorio’s 
research program has significantly expanded in the years 
that he has spent at Children’s, not only in the area of glial 
development and signaling, but also in neonatal brain injury 
and neural regeneration. His research has taken some excit-
ing new directions, including recent publications on neuro-
protection in congenital heart disease, in collaboration with 
Drs. Nobuyuki Ishibashi and Richard Jonas, both prominent 
clinician scientists at CNRI. In these studies, Vittorio and 
his colleagues used the piglet to study cellular dynamics 
associated with developmental brain injury, as the brain of 
this animal model is particularly close to human, including 
its white matter and subventricular zone structures.
At CNRI, Vittorio has built a successful Center for Neu-
roscience Research, which currently includes more than 50 
investigators—12 of them lab-based developmental and 
translational neuroscientists. During these years at CNRI, 
he has also served as Professor of Pediatrics, Pharmacology 
and Physiology at the George Washington University School 
of Medicine and Health Sciences, and Adjunct Professor, 
Child Study Center, Yale University School of Medicine. 
In 2017, he was elevated to the position of Chief Research 
Officer, Children’s National Hospital and Associate Dean 
for Child Health Research, George Washington University 
School of Medicine and Health Sciences. In his new role as 
Chief Research Officer, he is not only responsible for a num-
ber of CNRI programs at the institution, but he continues 
to focus his efforts in integrating clinical and translational 
research at Children’s National and create opportunities for 
synergistic collaborations among investigators at different 
CNRI centers.
Vittorio has received a large number of national and 
international Awards, including the NINDS Javits Award 
in Neuroscience in 2018. His research efforts which started 
by fundamental studies of glutamatergic and GABAergic 
neurotransmission have evolved into detailed studies of glio-
genesis and neurogenesis in the developing brain and the 
potential of stem/progenitor cells in regeneration and repair 
particularly in the developing white matter. In the course of 
these studies, he has uncovered new cellular and molecular 
mechanisms to promote protection and regeneration. His 
scientific success is attested by over 130 peer-reviewed pub-
lications—many in very high-profile journals—as well as 
over 30 review articles and book chapters. He has served on 
the Editorial Boards of many neuroscience journals, includ-
ing Glia, and has been Reviewing Editor for The Journal 
of Neuroscience, all of which is a testament to the tremen-
dous impact that his studies have had on the advancement 
of neurosciences.
Vittorio continues to dedicate a large proportion of his 
time to one of his greatest passions—mentoring of gradu-
ate students, postdoctoral fellows, and clinician scientists at 
different stages of their careers. During his career, he has 
mentored more than 50 postdoctoral fellows and graduate 
students. Many of these currently hold academic positions 
in the US and abroad. He has also mentored more than 30 
junior PhD and MD faculties, who have obtained a variety 
of NIH awards, including many career transition awards. 
In his current roles, not only does he play a major role in 
establishing the programmatic vision of CNRI, but he is 
also responsible for recruitments of new faculty and for their 
mentorship at all levels. He has made diversity and inclusion 
one of his priorities in all his efforts, and not only created 
NIH-sponsored training programs with a large percentage of 
minority trainees, but also recruited a diverse faculty pool.
Arne Schousboe
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